3 medicines held by Bristol-Myers Squibb Pharmaceuticals uc on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Abecma 260 - 500 x 106 cells dispersion for infusion EU/1/21/1539/001 |
Idecabtagene Vicleucel | Bristol-Myers Squibb Pharmaceuticals uc | — |
| INREBIC 100 mg hard capsules EU/1/20/1514/001 |
Fedratinib dihydrochloride monohydrate, Fedratinib | Bristol-Myers Squibb Pharmaceuticals uc | — |
| Thalidomide BMS 50 mg hard capsules EU/1/08/443/1 |
Thalidomide | Bristol-Myers Squibb Pharmaceuticals uc | — |
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.